← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2006Last known activity
Sep 9, 2024
Timeline
1950s
- Jun 1, 1959
HAL Allergy— Founded
Drugs by trial phase (7 distinct, 15 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT06920771Lead sponsorPhase 3Sep 9, 2024
- NCT03758456Lead sponsorPhase 1Nov 21, 2018
- NCT02991885Lead sponsorPhase 1Dec 1, 2016
- NCT02556801Lead sponsorPhase 2Sep 1, 2015
- NCT02345278Lead sponsorPhase 1/Phase 2May 1, 2015
- NCT02231307Lead sponsorPhase 3Sep 1, 2014
- NCT02163018Lead sponsorPhase 1Jun 1, 2014
- NCT01918956Lead sponsorPhase 4Sep 1, 2013
- NCT01682070Lead sponsorPhase 2Sep 1, 2012
- NCT01639768Lead sponsorPhase 2Jul 1, 2012
- NCT01438463Lead sponsorPhase 2Sep 1, 2011
- NCT01059266Lead sponsorPhase 4Feb 1, 2010
- NCT00973453Lead sponsorPhase 2Aug 1, 2009
- NCT00932607Lead sponsorPhase 2Jul 1, 2009
- NCT00422149Lead sponsorPhase 3Sep 1, 2006
Details
- Founded
- Leiden, NL Jun 1, 1959
- Last known activity
- Sep 9, 2024